Clinical Trials Cultivation Data Safety 
Cannabis Law Report
JUNE 16, 2021
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.
Cannabis Law Report
OCTOBER 6, 2021
Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
AUGUST 22, 2022
Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. Quite frankly, the clinical trials couldn’t have come at a better time.
Cannabis Law Report
SEPTEMBER 12, 2022
All Optimi mushroom products are grown from the Company’s world-leading psilocybin genetic bank and are grown in EU-GMP compliant clean rooms that ensure sterile cultivation and undergo almost 300 different analytical tests post-harvest. The harvest includes the following psilocybin-containing mushroom strains: Koh Samui. Penis Envy.
Cannabis Law Report
JULY 30, 2019
Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. The consultation covers proposed licensing, cultivation, manufacturing and product standards, and a prescription and enforcement regime.
Veriheal
APRIL 11, 2022
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. Fortunately, the U.S. This means that U.S.
Cannabis Law Report
FEBRUARY 9, 2022
But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research. For example, under the draft rules, manufacturers can only cultivate one mushroom species: Psilocybe cubensis.
Expert insights. Personalized for you.
104 
Let's personalize your content